Geraint  Phillips net worth and biography

Geraint Phillips Biography and Net Worth

Geraint Phillips is currently the Senior Vice President-Global Operations at BioLife Solutions, Inc. He previously worked as the Senior Director-BioRepository Operations at Azenta US, Inc. from 2019 to 2020, the Vice President-Global Operations at Revvity, Inc. from 2007 to 2016, the Chief Operations Officer at Global Cooling, Inc. from 2020 to 2021, and the Vice President-Global Operations at Humanscale Corp. from 2016 to 2019.

He obtained an undergraduate degree from the University of Cardiff and an MBA from the University of South Wales.

What is Geraint Phillips' net worth?

The estimated net worth of Geraint Phillips is at least $1.59 million as of March 11th, 2024. Phillips owns 69,596 shares of BioLife Solutions stock worth more than $1,588,877 as of April 2nd. This net worth evaluation does not reflect any other investments that Phillips may own. Learn More about Geraint Phillips' net worth.

How do I contact Geraint Phillips?

The corporate mailing address for Phillips and other BioLife Solutions executives is 3303 MONTE VILLA PARKWAY SUITE 310, BOTHELL WA, 98021. BioLife Solutions can also be reached via phone at (425) 402-1400 and via email at rdegreef@biolifesolutions.com. Learn More on Geraint Phillips' contact information.

Has Geraint Phillips been buying or selling shares of BioLife Solutions?

Geraint Phillips has not been actively trading shares of BioLife Solutions during the last ninety days. Most recently, Geraint Phillips sold 206 shares of the business's stock in a transaction on Monday, March 11th. The shares were sold at an average price of $17.42, for a transaction totalling $3,588.52. Following the completion of the sale, the senior vice president now directly owns 69,596 shares of the company's stock, valued at $1,212,362.32. Learn More on Geraint Phillips' trading history.

Who are BioLife Solutions' active insiders?

BioLife Solutions' insider roster includes Sarah Aebersold (VP), Todd Berard (CMO), Roderick de Greef (CFO), Amy Duross (Director), Karen Foster (Insider), Andrew Hinson (Director), Aby Mathew (VP), Geraint Phillips (SVP), Michael Rice (CEO), Garrie Richardson (CRO), Joseph Schick (Director), Marcus Schulz (CRO), Sean Werner (Chief Technology Officer), and Troy Wichterman (CFO). Learn More on BioLife Solutions' active insiders.

Are insiders buying or selling shares of BioLife Solutions?

In the last twelve months, insiders at the medical equipment provider sold shares 67 times. They sold a total of 177,061 shares worth more than $3,974,276.73. The most recent insider tranaction occured on March, 17th when insider Sarah Aebersold sold 2,695 shares worth more than $68,560.80. Insiders at BioLife Solutions own 2.2% of the company. Learn More about insider trades at BioLife Solutions.

Information on this page was last updated on 3/17/2025.

Geraint Phillips Insider Trading History at BioLife Solutions

See Full Table

Geraint Phillips Buying and Selling Activity at BioLife Solutions

This chart shows Geraint Phillips's buying and selling at BioLife Solutions by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20k$0$20kTotal Insider BuyingTotal Insider Selling

BioLife Solutions Company Overview

BioLife Solutions logo
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
Read More

Today's Range

Now: $22.83
Low: $21.89
High: $23.80

50 Day Range

MA: $26.19
Low: $22.83
High: $28.49

2 Week Range

Now: $22.83
Low: $14.84
High: $29.55

Volume

788,515 shs

Average Volume

357,735 shs

Market Capitalization

$1.07 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.04